EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Scientific understanding of advanced therapeutic strategies for nonexudative age-related macular degeneration in 2025

Hanna Wołodkiewicz, Marta Wolszczak, Grzegorz Gruba, Joanna Przybek-Skrzypecka, Michał Post, Jacek P. Szaflik, Justyna Izdebska

OphthaTherapy. Therapies in Ophthalmology · 31.12.2025 · 12 (4) · 360-369

DOI: 10.24292/01.ot.150126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OphthaTherapy. Therapies in Ophthalmology, online erschienen am 31.12.2025. Verfasst von Hanna Wołodkiewicz und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Age-related macular degeneration is one of the most common causes of severe vision loss in the developed world. Advanced forms of age-related macular degeneration are seen in primarily 2 types, exudative type involving the presence of choroidal neovascularization, and nonexudative age-related macular degeneration with geographic atrophy. The more prevalent form of age-related macular degeneration is nonexudative type, yet with less definitive treatment options. The emergence of anti-VEGF has revolutionized the treatment of exudative type. For nonexudative age-related macular degeneration, vitamins and minerals supplementation known as the AREDS 2 formulation remains a primary care strategy. Recently, two intravitreal anti-complement factors have been approved as a novel treatment – pegcetacoplan and avacincaptad pegol. Many other therapeutic pathways are still being investigated, including stem cell therapy, gene therapy, laser treatment, photobiomodulation, neuroprotective and antioxidant agents, and also surgical options. In this review, we provide an update on prospective treatment options for the management of nonexudative age-related macular degeneration and preventing the progression of geographic atrophy.

Zitieren

APA

Wołodkiewicz, H., Wolszczak, M., Gruba, G., Przybek-Skrzypecka, J., Post, M., Szaflik, J. P., & Izdebska, J. (2025). Scientific understanding of advanced therapeutic strategies for nonexudative age-related macular degeneration in 2025. OphthaTherapy. Therapies in Ophthalmology, 12(4), 360-369. https://doi.org/10.24292/01.ot.150126

Vancouver

Wołodkiewicz H, Wolszczak M, Gruba G, Przybek-Skrzypecka J, Post M, Szaflik JP, et al. Scientific understanding of advanced therapeutic strategies for nonexudative age-related macular degeneration in 2025. OphthaTherapy. Therapies in Ophthalmology. 2025;12(4):360-369. doi:10.24292/01.ot.150126

BibTeX
@article{Woodkiewicz2025,
  author = {Wołodkiewicz, Hanna and Wolszczak, Marta and Gruba, Grzegorz and Przybek-Skrzypecka, Joanna and Post, Michał and Szaflik, Jacek P. and Izdebska, Justyna},
  title = {Scientific understanding of advanced therapeutic strategies for nonexudative age-related macular degeneration in 2025},
  journal = {OphthaTherapy. Therapies in Ophthalmology},
  year = {2025},
  volume = {12},
  number = {4},
  pages = {360--369},
  doi = {10.24292/01.ot.150126}
}
Kostenlos starten →